Pierre Remy

Pierre Remy is a Founding Partner and Managing Partner of Keensight Capital, where he leads the firm’s Healthcare & Wellbeing practice. Keensight describes him as actively involved in developing companies across healthcare areas including large joints, spine, dental, cardiovascular, drug delivery, in-vitro diagnostics, small-molecule CMO, biopharmaceutical CDMO, biomaterials development, and nutraceuticals.

Before Keensight, Remy spent 10 years with Rothschild & Co as a Managing Partner of R Capital, Rothschild Group’s investment arm dedicated to growth companies. In 2013, R Capital Management became independent under the Keensight Capital name, with the team led by Jean-Michel Beghin, Jérôme Pujol, and Pierre Rémy.

Earlier in his career, Remy worked as an engineer focused on supply-chain transformation and productivity improvement. He graduated from Sciences Po Paris and holds an engineering degree from ENSAM Paris.

• Keensight’s stated strategy is to “partner with the management teams of fast growing and profitable companies” by providing capital, strategic guidance, and operational support.
• The firm invests in European Growth Buyout situations: profitable private companies with strong growth, in minority or majority positions, with or without leverage.
• Keensight’s current ticket range is €10 million to €800 million; its target companies typically generate €10 million to €400 million in revenue.
• Remy’s personal practice focus is Healthcare & Wellbeing, including medtech, pharma services/CDMO, diagnostics, biomaterials, nutraceuticals, and related healthcare niches.
• Keensight uses flexible capital for organic growth, strategic acquisitions, and liquidity for existing shareholders.
• The firm emphasizes operational value creation through its Keensight Performance team, sector specialization, international expansion, M&A, pricing, sales excellence, supply chain, and ESG integration.